RTX vs TERN
RTX Corporation (RTX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. TERN currently screens at market cap $6.12B.
Not investment advice. Open the RTX and TERN stock pages for the full models.
Not investment advice.